David Hung Launches Start-Up Nuvation With Old Medivation Team And $275m

 
• By Mandy Jackson

The former Medivation CEO, after a brief detour heading up Axovant, is returning to oncology, but the new company is keeping details about the seven cancer drug programs in its pipeline under wraps.

SC1910_Businessman-sketch_150613505_1200.jpg
Start-up Nuvation has seven cancer drug programs but intends to expand its pipeline. • Source: Shutterstock

More from Financing

More from Business